Peter M. Mathisen

1.1k total citations
23 papers, 957 citations indexed

About

Peter M. Mathisen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Peter M. Mathisen has authored 23 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Peter M. Mathisen's work include Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (6 papers) and T-cell and B-cell Immunology (5 papers). Peter M. Mathisen is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (6 papers) and T-cell and B-cell Immunology (5 papers). Peter M. Mathisen collaborates with scholars based in United States. Peter M. Mathisen's co-authors include Vincent K. Tuohy, Justin M. Johnson, Min Yu, Lawrence W. Miller, Julie A. Kawczak, Judith Drazba, Richard D. Peppler, Richard A. Rudick, R. M. Ransohoff and Mingkun Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Peter M. Mathisen

23 papers receiving 927 citations

Peers

Peter M. Mathisen
M P Burgoon United States
Joachim Malotka Germany
J.G. Seidman United States
Christoph Schubert Germany
Satu Kuokkanen United States
Mayumi Matsunaga Japan
Ethan W. Ojala United States
Bert ’t Hart Netherlands
Sophie Godard France
Huihong Xu United States
M P Burgoon United States
Peter M. Mathisen
Citations per year, relative to Peter M. Mathisen Peter M. Mathisen (= 1×) peers M P Burgoon

Countries citing papers authored by Peter M. Mathisen

Since Specialization
Citations

This map shows the geographic impact of Peter M. Mathisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Mathisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Mathisen more than expected).

Fields of papers citing papers by Peter M. Mathisen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Mathisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Mathisen. The network helps show where Peter M. Mathisen may publish in the future.

Co-authorship network of co-authors of Peter M. Mathisen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Mathisen. A scholar is included among the top collaborators of Peter M. Mathisen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Mathisen. Peter M. Mathisen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathisen, Peter M.. (2003). Gene discovery and validation for neurodegenerative diseases. Drug Discovery Today. 8(1). 39–46. 12 indexed citations
2.
Yin, Ling, Canqing Yu, Andrea E. Edling, et al.. (2001). Pre-Emptive Targeting of the Epitope Spreading Cascade with Genetically Modified Regulatory T Cells During Autoimmune Demyelinating Disease. The Journal of Immunology. 167(11). 6105–6112. 11 indexed citations
3.
Mathisen, Peter M., Julie A. Kawczak, Min Yu, Justin M. Johnson, & Vincent K. Tuohy. (2001). Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis. Journal of Neuroscience Research. 64(5). 542–551. 10 indexed citations
4.
Tuohy, Vincent K. & Peter M. Mathisen. (2000). T cell design for therapy in autoimmune demyelinating disease. Journal of Neuroimmunology. 107(2). 226–232. 7 indexed citations
5.
Mathisen, Peter M. & Vincent K. Tuohy. (2000). Gene Therapy in Experimental Autoimmune Encephalomyelitis. Journal of Clinical Immunology. 20(5). 327–333. 4 indexed citations
6.
Tuohy, Vincent K., Min Yu, Ling Yin, et al.. (2000). Modulation of the IL-10/IL-12 cytokine circuit by interferon-β inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis. Journal of Neuroimmunology. 111(1-2). 55–63. 63 indexed citations
7.
Mathisen, Peter M., Justin M. Johnson, Julie A. Kawczak, & Vincent K. Tuohy. (1999). Visinin-like Protein (VILIP) Is a Neuron-specific Calcium-dependent Double-stranded RNA-binding Protein. Journal of Biological Chemistry. 274(44). 31571–31576. 27 indexed citations
8.
Mathisen, Peter M., Min Yu, Ling Yin, et al.. (1999). Th2 T cells Expressing Transgene PDGF-A Serve as Vectors for Gene Therapy in Autoimmune Demyelinating Disease. Journal of Autoimmunity. 13(1). 31–38. 14 indexed citations
9.
Mathisen, Peter M. & Vincent K. Tuohy. (1999). Gene therapy for autoimmune demyelinating disease of the central nervous system.. PubMed. 47(1). 33–5. 1 indexed citations
10.
Mathisen, Peter M.. (1998). Gene therapy in the treatment of autoimmune disease. Immunology Today. 19(3). 103–105. 24 indexed citations
11.
Tuohy, Vincent K. & Peter M. Mathisen. (1998). T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification. Research in Immunology. 149(9). 834–842. 9 indexed citations
12.
Tuohy, Vincent K., Min Yu, Ling Yin, et al.. (1998). The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunological Reviews. 164(1). 93–100. 139 indexed citations
13.
Kawczak, Julie A., Peter M. Mathisen, Judith Drazba, et al.. (1998). Digitized image analysis reveals diffuse abnormalities in normal‐appearing white matter during acute experimental autoimmune encephalomyelitis. Journal of Neuroscience Research. 54(3). 364–372. 8 indexed citations
14.
Rudick, Richard A., R. M. Ransohoff, Richard D. Peppler, et al.. (1998). In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Neurology. 50(5). 1294–1300. 194 indexed citations
15.
Mathisen, Peter M., Min Yu, Justin M. Johnson, Judith Drazba, & Vincent K. Tuohy. (1997). Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T Cells. The Journal of Experimental Medicine. 186(1). 159–164. 144 indexed citations
16.
Mathisen, Peter M., Justin M. Johnson, & Julie A. Kawczak. (1997). Stabilization of myelin mRNAs as measured in a brain slice system. Journal of Neuroscience Research. 50(6). 1030–1039. 8 indexed citations
17.
Mathisen, Peter M., Shirley Pease, James E. Garvey, Leroy Hood, & Carol Readhead. (1993). Identification of an embryonic isoform of myelin basic protein that is expressed widely in the mouse embryo.. Proceedings of the National Academy of Sciences. 90(21). 10125–10129. 92 indexed citations
18.
Mathisen, Peter M. & Leo Miller. (1989). Thyroid Hormone Induces Constitutive Keratin Gene Expression during Xenopus laevis Development. Molecular and Cellular Biology. 9(5). 1823–1831. 1 indexed citations
19.
Mathisen, Peter M. & Lawrence W. Miller. (1989). Thyroid hormone induces constitutive keratin gene expression during Xenopus laevis development.. Molecular and Cellular Biology. 9(5). 1823–1831. 51 indexed citations
20.
Mathisen, Peter M. & Lawrence W. Miller. (1987). Thyroid hormone induction of keratin genes: a two-step activation of gene expression during development.. Genes & Development. 1(10). 1107–1117. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M P Burgoon Breakdown of academic impact, for papers by Joachim Malotka Breakdown of academic impact, for papers by J.G. Seidman Breakdown of academic impact, for papers by Christoph Schubert Breakdown of academic impact, for papers by Satu Kuokkanen Breakdown of academic impact, for papers by Mayumi Matsunaga Breakdown of academic impact, for papers by Ethan W. Ojala Breakdown of academic impact, for papers by Bert ’t Hart Breakdown of academic impact, for papers by Sophie Godard Breakdown of academic impact, for papers by Huihong Xu
Rankless by CCL
2026